Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.
about
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerMyoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats.Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis.Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoidTransgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.Overexpression of connexin26 in the basal keratinocytes reduces sensitivity to tumor promoter TPA.Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib.
P2860
Q28218639-0E8229EB-430E-4AE7-9477-75CC31B17410Q31047373-B74E695F-3997-449C-A347-70D3CD6CF186Q33664316-AFCC0C46-9878-458E-9EBB-B6DD51DC4D6FQ36090487-49F1B2FB-AEA9-4530-8697-6C610A37405CQ36456638-72E2BD90-E7B7-4125-A235-D6D280CB4C20Q36572139-BE4D9A3C-4E0F-48FE-9FE6-A9E645828198Q36787635-ABF750DC-43D6-4799-8964-D64D5E1DDEEAQ36839265-7EB75057-D1FF-4863-A3AD-23FD76A7EEBEQ36855753-BBAB45F0-83E1-46E8-9A65-41C74C16CA58Q37033840-FFFB5CE9-2D04-49F9-857E-67ABA09F01F7Q37215586-F6DA41DB-6FAD-4E8B-B412-34D72F7DD324Q37405065-02C6DF60-222F-4B63-BD6A-4B2CF73CA489Q42464171-DB54FED1-502C-4433-A443-17FE0AA2C688Q46236774-2D1BD85C-9DDC-4D19-A481-3163D042A39AQ46827099-5E0F0346-1577-4DD9-BA58-698640B15857Q47803989-E355CA42-1127-4A3D-B5B6-DBB4E892BB43
P2860
Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@ast
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@en
type
label
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@ast
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@en
prefLabel
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@ast
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@en
P2093
P2860
P1476
Cystic duct dilatations and pr ...... xpression of cyclooxygenase-2.
@en
P2093
Gerhard Fürstenberger
Irina Berger
Karin Ackermann
Karin Müller-Decker
Sebastian Aulmann
Svetlana Zoubova
Volker Ehemann
Walter Pyerin
P2860
P304
P356
10.1016/S0002-9440(10)62279-1
P407
P577
2005-02-01T00:00:00Z